Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00373932 · ClinicalTrials.gov registry record · Phase 1

Real-Time Support for Exercise Persistence in COPD

A Phase 1 study of COPD and Pulmonary Disease, Chronic Obstructive, sponsored by University of Washington.

Completed
Registry status
Phase 1
Development phase
17
Enrollment target
1
Study location

NCT00373932: Completed Phase 1 study of COPD and Pulmonary Disease, Chronic Obstructive, sponsored by University of Washington.

NCT00373932 is a Phase 1 study of COPD and Pulmonary Disease, Chronic Obstructive that has completed, run by University of Washington. The registered enrollment target is 17 participants, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00373932, a Phase 1 study of COPD and Pulmonary Disease, Chronic Obstructive, has completed, sponsored by University of Washington.

COMPLETED
Registry status
Phase 1
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

The purpose of this exploratory study is to determine the feasibility, acceptability, and efficacy of an exercise persistence intervention for patients with chronic obstructive pulmonary disease (COPD) following pulmonary rehabilitation (PR).

Interventions

  • BEHAVIORAL Coached exercise persistence intervention
  • BEHAVIORAL Self-Monitored exercise persistence intervention

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2006-05
Est. Completion 2008-12
Phase Phase 1
University of Washington

1,048 total trials

What the finished NCT00373932 record still lists

NCT00373932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with COPD appearing as the primary indexed condition, and to 2 interventions - of which Coached exercise persistence intervention is the first listed.

NCT00373932 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT00373932 about?

NCT00373932 is a clinical study titled "Real-Time Support for Exercise Persistence in COPD". The purpose of this exploratory study is to determine the feasibility, acceptability, and efficacy of an exercise persistence intervention for patients with chronic obstructive pulmonary disease (COPD) following pulmonary rehabilitation (PR).

What is the current status of trial NCT00373932?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2006-05. Estimated completion is 2008-12.

What conditions does trial NCT00373932 study?

This clinical trial studies the following conditions: COPD, Pulmonary Disease, Chronic Obstructive, Emphysema, Chronic Bronchitis.

What interventions are being tested in trial NCT00373932?

The interventions under investigation include: Coached exercise persistence intervention (BEHAVIORAL), Self-Monitored exercise persistence intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00373932?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00373932 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00373932's enrollment target sits among peer trials

17 78th of 85 higher than 8 of 85 other COPD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00373932, the US trial registry maintained by the National Library of Medicine. NCT00373932 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.